Activation and disease control of patients on chronic hemodialysis: An observational study

Sara Ramírez-Sánchez1, María Jesús Soriano-Munuera2, Elena Lucia Gras-Colomer3

  • 1Bioquímica y Ciencias Biomédicas, Universitat de València, Valencia, Spain.

Nefrologia
|June 15, 2024
PubMed

Insights

Patient activation, the willingness to manage health, is low in hemodialysis patients. Higher activation correlates with arteriovenous fistulas, better blood flow, and less interdialytic weight gain.

Area of Science:

  • Nephrology
  • Patient Health Management
  • Chronic Disease Care

Background:

  • Patient activation is crucial for managing health, but often low in chronic disease patients.
  • Limited data exists on patient activation levels in hemodialysis populations.
  • This study addresses the gap in understanding hemodialysis patient activation.

Purpose of the Study:

  • To assess the patient activation level in individuals undergoing chronic hemodialysis.
  • To investigate the relationship between patient activation and key disease control parameters in hemodialysis patients.

Main Methods:

  • A cross-sectional observational study involving 96 hemodialysis patients.
  • Patient activation was measured using the Patient Activation Measure (PAM-13) questionnaire.
  • Statistical analyses included Spearman's correlation, multiple linear regression, and logistic regression.

Main Results:

  • The average PAM-13 score was 63.19 (±15.21), indicating generally low activation.
  • Significant associations were found between activation levels and vascular access type (P=0.003).
  • Higher activation correlated with increased blood flow (P=0.024) and lower interdialytic weight gain (P=0.008).

Conclusions:

  • Patient activation is notably low among patients receiving chronic hemodialysis.
  • Favorable indicators include arteriovenous fistula use, higher blood flow, and reduced interdialytic weight gain.
  • Further research is recommended to validate and implement these findings in clinical practice.
Abstract

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
80
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
567